专题：Allergic Rhinitis and Sensitization

This cluster of papers focuses on the impact of allergic rhinitis on asthma, including allergen-specific immunotherapy, immunological mechanisms, and the influence of environmental factors such as pollen allergy and climate change. It also addresses the epidemiology, quality of life, and management strategies for allergic rhinitis and its comorbidity with asthma.
最新文献
Communicating Anaphylaxis Risk in Pediatric Allergy Consultations: A Conversation Analytic Study

article Full Text OpenAlex

Analysis of adverse reaction characteristics of four biologics for the treatment of chronic sinusitis with nasal polyps: A descriptive analysis from WHO-VigiAccess

article Full Text OpenAlex

A multidisciplinary Delphi consensus on the modern definition of pruritus: Sensation and disease

article Full Text OpenAlex

Decoding Penaeus vannamei Allergies: How Digestion-Resistant Immunodominant Epitopes Drive IgE-Mediated Allergic Responses

article Full Text OpenAlex

Treating allergic rhinitis by thinking globally and acting locally

editorial Full Text OpenAlex

Current insights and trends in atopic dermatitis and microbiota interactions: a systematic review and bibliometric analysis

review Full Text OpenAlex

Global, regional and national burdens of atopic dermatitis from 1990 to 2021: a trend analysis from the Global Burden of Disease Study 2021.

article Full Text OpenAlex

Psoriasis Risk in Patients With Atopic Dermatitis Treated With Dupilumab

article Full Text OpenAlex

Current Understanding of Epithelial-Derived Alarmins in Chronic Rhinosinusitis with Nasal Polyps

review Full Text OpenAlex

Do Skin Prick Tests Predict Nasal Provocation Test Outcomes in Allergic Rhinitis Patients?

article Full Text OpenAlex

近5年高被引文献
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040

article Full Text OpenAlex 947 FWCI129.85

Atopic Dermatitis

review Full Text OpenAlex 528 FWCI19.756

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial

letter Full Text OpenAlex 453 FWCI0

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020

article Full Text OpenAlex 441 FWCI64.091

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

article Full Text OpenAlex 441 FWCI90.327

Molecular Mechanisms of Atopic Dermatitis Pathogenesis

review Full Text OpenAlex 402 FWCI14.399

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

article Full Text OpenAlex 367 FWCI76.849

Atopic dermatitis in the pediatric population

article Full Text OpenAlex 347 FWCI65.972

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

article Full Text OpenAlex 323 FWCI38.15

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

article Full Text OpenAlex 323 FWCI46.733